| Document and Entity Information | 6 Months Ended | |
| Feb. 28, 2015 | Apr. 13, 2015 | |
| Document And Entity Information | ||
| Entity Registrant Name | MIX 1 LIFE, INC. | |
| Entity Central Index Key | 1501112 | |
| Document Type | 10-Q | |
| Document Period End Date | 28-Feb-15 | |
| Amendment Flag | FALSE | |
| Current Fiscal Year End Date | -23 | |
| Is Entity a Well-known Seasoned Issuer? | No | |
| Is Entity a Voluntary Filer? | No | |
| Is Entity's Reporting Status Current? | Yes | |
| Entity Filer Category | Smaller Reporting Company | |
| Entity Common Stock, Shares Outstanding | 11,383,111 | |
| Document Fiscal Period Focus | Q2 | |
| Document Fiscal Year Focus | 2015 |
| BALANCE SHEETS (USD $) | Feb. 28, 2015 | Aug. 31, 2014 |
| Current Assets: | ||
| Cash and cash equivalents | $42,596 | $91,794 |
| Inventory, lower of cost or market, principally first-in, first-out | 183,845 | 580,607 |
| Accounts receivable | 736,868 | |
| Notes receivable | 129,900 | |
| Other current Assets | 14,733 | 27,963 |
| Total Current Assets | 1,107,942 | 700,364 |
| Fixtures and Equipment, net of accumulated depreciation of $964 at February 28, 2015 and $413 at August 31, 2014 | 16,324 | 5,375 |
| Ingredient Specifications, Branding, and Other Intangible Assets, net of accumulated amortization of $859,287 at February 28 2015, and zero at August 31, 2014 | 19,020,713 | 19,880,000 |
| TOTAL ASSETS | 20,144,979 | 20,585,739 |
| Current Liabilities: | ||
| Accounts payable and accrued liabilities | 152,062 | 218,330 |
| Accounts payable - related parties | 367,521 | 349,038 |
| Notes payable - premium finance | 14,733 | 15,932 |
| Total Current Liabilities | 534,316 | 583,300 |
| 12% Senior Secured Convertible Debenture | 1,384,000 | 500,000 |
| Total Liabilities | 1,918,316 | 1,083,300 |
| Shareholders' Equity: | ||
| Common Stock, $0.001 par value, 100,000,000 shares authorized 11,486,670 and 10,880,796 shares issued and outstanding at February 28, 2015 and August 31, 2014 respectively | 11,487 | 10,881 |
| Additional paid-in-capital | 22,684,063 | 21,547,848 |
| Accumulated (deficit) | -4,468,887 | -2,056,290 |
| Total Shareholders' Equity | 18,226,663 | 19,502,439 |
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $20,144,979 | $20,585,739 |
| BALANCE SHEETS (Parenthetical) (USD $) | Feb. 28, 2015 | Aug. 31, 2014 |
| Current Assets: | ||
| Fixtures and Equipment, net of accumulated depreciation of $964 at February 28, 2015 and $413 at August 31, 2014 | $964 | $413 |
| Ingredient Specifications, Branding, and Other Intangible Assets, net of accumulated amortization of $859,287 at February 28 2015, and zero at August 31, 2014 | $859,287 | $0 |
| Current Liabilities: | ||
| Senior Secured Convertible Debenture | 12.00% | 0.00% |
| Stockholders' Equity | ||
| Common stock, par value | $0.00 | $0.00 |
| Common stock, shares authorized | 100,000,000 | 100,000,000 |
| Common stock, shares issued | 11,486,670 | 10,880,796 |
| Common stock, shares outstanding | 11,486,670 | 10,880,796 |
| STATEMENTS OF OPERATIONS (Unaudited) (USD $) | 3 Months Ended | 6 Months Ended | ||
| Feb. 28, 2015 | Feb. 28, 2014 | Feb. 28, 2015 | Feb. 28, 2014 | |
| Statements Of Operations | ||||
| Gross Sales | $506,756 | $749,231 | ||
| Customer incentives, discounts, returns, and allowances | -2,381 | -2,381 | ||
| Net sales | 504,375 | 746,850 | ||
| Costs of goods sold | 445,667 | 657,707 | ||
| Gross Margin | 58,708 | 89,143 | ||
| Operating Expenses | ||||
| Selling and marketing | 324,817 | 16,201 | 369,133 | 23,934 |
| Corporate general and administrative | 475,372 | 459,650 | 963,597 | 749,736 |
| Depreciation and amortization expense | 429,988 | 859,838 | ||
| Total operating expenses | 1,230,177 | 475,851 | 2,192,568 | 773,670 |
| Loss from Operations | -1,171,469 | -475,851 | -2,103,425 | -773,670 |
| Other (Expenses) | ||||
| Interest expense | -215,284 | -402,396 | -309,172 | -402,396 |
| Loss before income taxes | -1,386,753 | -878,247 | -2,412,597 | -1,176,066 |
| Provision for Income Taxes | ||||
| Net (Loss) | ($1,386,753) | ($878,247) | ($2,412,597) | ($1,176,066) |
| Basic and fully diluted: | ||||
| Weighted average number of shares outstanding | 11,441,513 | 9,885,338 | 11,297,073 | 9,856,718 |
| (Loss) per share | ($0.12) | ($0.09) | ($0.21) | ($0.12) |
| STATEMENTS OF CASH FLOW (Unaudited) (USD $) | 6 Months Ended | |
| Feb. 28, 2015 | Feb. 28, 2014 | |
| Cash flows from operating activities: | ||
| Net (loss) | ($2,412,597) | ($1,176,066) |
| Adjustments to reconcile net (loss) to net cash used in operating activities: | ||
| Common stock issued for services | 29,655 | |
| Common stock issued for services - related parties | 150,202 | 194,780 |
| Common stock issued for officers' and directors' fees | 37,497 | 114,000 |
| Common stock issued for interest | 22,683 | |
| Convertible note loan fees | 194,445 | |
| Valuation of warrants on convertible debt | 259,434 | 196,835 |
| Depreciation and Amortization | 859,838 | |
| Changes in Current Assets and Liabilities | ||
| Inventory | 396,762 | |
| Accounts receivable | -736,868 | |
| Notes receivable | -129,900 | |
| Other current assets | 13,230 | -44,070 |
| Accounts payable and accrued liabilities | -66,268 | 68,322 |
| Accounts payable - related parties | 18,483 | 24,352 |
| Net cash (used) in by operating activities | -1,557,849 | -427,402 |
| Cash flows from investing activities: | ||
| Purchase of vehicles | -11,500 | -5,788 |
| Net cash provided by (used in) investing activities | -11,500 | -5,788 |
| Cash flows from financing activities | ||
| Loans from Officer | 30,400 | |
| Repayments to officer | -25,833 | |
| Convertible note proceeds | 884,000 | 500,000 |
| Sale of common stock | 637,350 | 283,000 |
| Note payable payment | -1,199 | |
| Net cash provided by financing activities | 1,520,151 | 787,567 |
| Net increase in cash and cash equivalents | -49,198 | 354,377 |
| Cash and cash equivalents, beginning of year | 91,794 | |
| Cash and cash equivalents, end of year | 42,596 | 354,377 |
| Cash paid during the year for: | ||
| Interest | 26,466 | |
| Income Taxes | ||
| Description of Business and Summary of Significant Accounting Policies | 6 Months Ended |
| Feb. 28, 2015 | |
| Notes to Financial Statements | |
| Note 1 - Description of Business and Summary of Significant Accounting Policies | Mix1 Life, Inc. (“the Company”) was incorporated under the laws of the State of Nevada, U.S. on June 10, 2009. |
| Mix1 is an emerging beverage and nutritional supplements company currently with a product line of natural, ready-to-drink protein shakes. Our shakes offer a complete and balanced macronutrient mix and are intended to be consumed as a post work out, snack replacement, meal supplement or a meal replacement. Mix1 beverages have a high protein content (on average 26 grams per serving) and are unique due to their fruit-based flavors, relatively low calorie count and superior taste. Our shakes have a twelve month shelf life with no need for refrigeration and are currently served in a twelve ounce PET (polyethylene terephthalate) bottle. | |
| The Company adopted the provisions of FASB Accounting Standards Update No. 2014-10 Development Stage Entities (Topic 915) (“the Update”) in these financials statements. The Update removes the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities to: (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. For the public business entities, the amendment is effective for annual reporting periods beginning after December 14, 2014. The requirements of this pronouncement do not have a material effect on the financial statements. | |
| The accompanying unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s annual report filed with the SEC on its 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for our interim period are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that would substantially duplicate the disclosure contained in the audited financial statements for the year ended August 31, 2014, as reported in the Form 10-K, have been omitted. | |
| There financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has limited cash and, as yet, has not generated any substantial revenues, raising substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with existing cash on hand, sales, loans from investors and/or issuance of common shares. |
| Concentration | 6 Months Ended |
| Feb. 28, 2015 | |
| Notes to Financial Statements | |
| Note 2 - Concentration | During the six months ended February 28, 2015, the Company had revenues and receivable of $746,850 and $736,868, respectively. Of these amounts, 93% of the revenues and 95% of the receivable were from Shadow Beverage and Snack, LLC. |
| Stock Transactions | 6 Months Ended |
| Feb. 28, 2015 | |
| Notes to Financial Statements | |
| Note 3 - Stock Transactions | During the six months ending February 28, 2015, the Company sold 483,834 shares of its common stock in private placements for $1.50 per share. There were 75,434 shares of common stock issued to related parties as payroll and consulting fees valued at $150,201, 19,167 shares were issued as officer and directors fees valued at $37,497, and 7,561 shares of common stock were issued as interest expense valued at $22,683. |
| Convertible Note | 6 Months Ended |
| Feb. 28, 2015 | |
| Notes to Financial Statements | |
| Note 4 - Convertible Note | During the six months ending February 28, 2015 the Company entered into convertible debt agreements for $884,000. Terms of these transactions include an annual interest rate of 12% due in two years, the option to convert debt into equity at $3.00 per share, and 147,335 stock purchase warrants. The warrants were valued using the Black Scholes valuation method at $259,429 calculated using a stock price of $6.12, a 5 year term, risk-free rate of interest of 1.64% and a volatility of 16.12%. |
| Subsequent Events | 6 Months Ended |
| Feb. 28, 2015 | |
| Notes to Financial Statements | |
| Note 5 - Subsequent Events | On March 31, 2015, the Company and Shadow Beverages and Snack, LLC, an Arizona limited liability company, closed upon that certain Asset Purchase Agreement for the purchase of the "No Fear" brand asset from Shadow. Shadow's interest in the No Fear brand is in the form of an exclusive Trademark and License Agreement between Shadow and No Fear International wherein Shadow was granted exclusive licensing and distribution of the No Fear drink within the United States of America. The Company acquired One Hundred Percent (100%) of Shadow's interest in the No Fear brand only for an aggregate purchase price of Twelve Million Two Hundred Thousand ($12,200,000) USD. |
| We have evaluated events and transactions after the balance sheet date to the date these financial statements were released for filing. Except as stated above, we did not have any material subsequent events that would require disclosure in these financial statements. |
| Concentration (Details Narrative) (USD $) | 3 Months Ended | 6 Months Ended | |||
| Feb. 28, 2015 | Feb. 28, 2014 | Feb. 28, 2015 | Feb. 28, 2014 | Aug. 31, 2014 | |
| Notes to Financial Statements | |||||
| Revenue | $504,375 | $746,850 | |||
| Accounts receivable | $736,868 | $736,868 | |||
| Stock Transactions (Details Narrative) (USD $) | 6 Months Ended |
| Feb. 28, 2015 | |
| Stock Transactions Details Narrative | |
| Sales of common stock | 483,834 |
| Sales of common stock private placement per share | $1.50 |
| Common stock issued to related parties as payroll and consulting fees | 75,434 |
| Common stock issued to related parties as payroll and consulting fees, Value | $150,201 |
| Shares issued as officer and directors fees | 19,167 |
| Shares issued as officer and directors fees, Value | 37,497 |
| Common stock issued as interest expense | 7,561 |
| Common stock issued as interest expense, Value | $22,683 |
| Convertible Note (Details Narrative) (USD $) | 6 Months Ended |
| Feb. 28, 2015 | |
| Convertible Note Details Narrative | |
| Convertible debt agreement | $884,000 |
| Annual interest rate | 12.00% |
| Annual interest payable date | 5-Nov-16 |
| Option to convert debt into equity | $3 |
| Stock purchase warrants | 147,335 |
| Warants valued | $259,429 |
| Stock price | $6.12 |
| Contractual term | 5 years |
| Risk-free rate of interest | 1.64% |
| Volatility rate | 16.12% |
